What is TransMedics Group, Inc.’s 1-month forecast?

Meyka AI projects TMDX could trade near $126.64 in the next month, a move of -4.28% compared to today’s price.

What is TransMedics Group, Inc.’s 1-year forecast?

By 2027, TMDX is forecasted to reach $142.10, reflecting a 7.41% change from the current level.

What is TransMedics Group, Inc.’s 5-year forecast?

The 2030 projection for TMDX is $239.32, which represents a potential 80.89% change.

What is the 7-year outlook for TransMedics Group, Inc.?

Over the next 7 years, TMDX could trade around $291.81, showing a 120.57% move from today’s price.

Can TransMedics Group, Inc. (TMDX) reach $290 by 2030?

Meyka AI’s 2030 forecast places TMDX at $239.32, making it unlikely to reach $290 by 2030 under current market conditions.

TransMedics Group, Inc.

TMDX•NASDAQ

Healthcare

Medical - Devices

$132.30

$-0.58(-0.44%)

U.S. Market is Open • 12:28

TransMedics Group, Inc. (TMDX) Stock Forecast & Price Predictions

Get the latest TransMedics Group, Inc. (TMDX) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$126.64

Change↓ $-5.66 (-4.28%)

Quarterly Forecast

Predicted Price$123.72

Change↓ $-8.58 (-6.49%)

Yearly Forecast

Predicted Price$142.10

Change↑ $9.80 (7.41%)

3 Years Forecast

Predicted Price$190.91

Change↑ $58.61 (44.30%)

5 Years Forecast

Predicted Price$239.32

Change↑ $107.02 (80.89%)

7 Years Forecast

Predicted Price$291.81

Change↑ $159.51 (120.57%)

TransMedics Group, Inc. Stock Forecast Summary

TransMedics Group, Inc. (TMDX) stock is currently priced at $132.30. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $126.64.

In the long term, TMDX shows a bullish trend. The 2027 forecast points to $142.10 (7.41% change), while the 2031 forecast suggests $239.32 (80.89% change). Looking 7 years ahead, projections estimate the stock could trade near $291.81, a 120.57% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that TransMedics Group, Inc. stock is expected to trade sideways over the coming years.

TransMedics Group, Inc. yearly Price Forecast Chart

Explore the yearly forecast chart for TMDX, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate TransMedics Group, Inc. over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for TMDXForecasting details for TMDX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

TransMedics Group, Inc. Stock Forecast 2026

The forecast for TransMedics Group, Inc. (TMDX) in 2026 suggests a price of $142.10, representing a 7.41% move from today’s price.

Average Target: $142.10

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

TransMedics Group, Inc. Stock Forecast 2030

By 2030, Meyka AI projects TMDX could trade near $239.32, showing a potential 80.89% compared to current levels.

Average Target: $239.32

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward TransMedics Group, Inc..

TransMedics Group, Inc. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for TMDX points to a price around $291.81, which is a projected 120.57% move from today’s level.

Average Target: $291.81

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
TransMedics Group, Inc.’s ability to maintain market leadership.